Gate2Brain
PrivateLast Round
Early Funding
Jun 16, 2026
Est. Valuation
$26.74M
Total Funding Raised
$6.02M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Gate2Brain operates in Healthcare & Life Sciences and is based in Barcelona. Its latest recorded funding round was a Convertible Debt round in November 2024.
Gate2Brain is a biotechnology company that has developed a peptide-based technology platform for delivering therapeutics across biological barriers, such as the blood-brain barrier.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Gate2Brain Comparables
Compare Gate2Brain with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Key2Brain | 85% | |
| Vect-Horus | 83% | |
| D2B3 | 82% |
For institutional investors. Book with your work email.
Gate2Brain Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jun 16, 2026 | ||||
| Convertible Debt | Nov 6, 2024 | ||||
| Grant | Dec 21, 2022 | ||||
| Grant | Jan 13, 2022 | ||||
| Grant | Dec 22, 2021 | ||||
Pre Seed | Jul 9, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Gate2Brain Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Fundación la Caixa | Grant |
| BStartup Health | Pre Seed |
| University of Barcelona | Grant |
| Center for Technological Development and Innovation | Grant |
| Fundación Botín | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors grew 97% MoM.
- Jun 20, 2026
Monthly visitors increased 52% MoM, reaching 1.2K.
For institutional investors. Book with your work email.
Gate2Brain Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Gate2Brain's valuation, stock price, and market status.
Is Gate2Brain a public or private company?
Gate2Brain is a private company.
What is the current stock price of Gate2Brain?
Gate2Brain is a private company, so its shares have no public market price. Caplight tracks Gate2Brain's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Gate2Brain worth (valuation)?
Gate2Brain's valuation is estimated at $26.7M based on funding round data.
Can I buy Gate2Brain stock?
Gate2Brain shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Gate2Brain's last funding round?
Gate2Brain's most recent funding round was Early Funding on June 16, 2026.
Who are the main investors in Gate2Brain?
Key investors in Gate2Brain include European Innovation Council Fund, Fundación la Caixa, BStartup Health, University of Barcelona, Center for Technological Development and Innovation.
Will Gate2Brain IPO soon?
No public IPO plans have been announced for Gate2Brain.
How can I track Gate2Brain secondary market activity?
Caplight tracks bids, offers, and trades in Gate2Brain's shares on secondary markets.